Christiane Rordorf
Department of Exploratory Clinical Development
Novartis Pharmaceuticals
Horsham
UK
Name/email consistency: high
- Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib. Scott, G., Vinluan Reynolds, C., Milosavljev, S., Langholff, W., Shenouda, M., Rordorf, C. Clin. Pharmacokinet (2004)
- Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects. Rordorf, C., Kellett, N., Mair, S., Ford, M., Milosavljev, S., Branson, J., Scott, G. Aliment. Pharmacol. Ther. (2003)